ACEi and ARBS in Hypertension and Heart Failure
https://libcat.nshealth.ca/en/permalink/provcat39106
Pasquale Perrone Filardi, editor.
--Cham:
Springer International Publishing : Imprint: Springer ; ISCP
, c2015.
- Available Online
- View e-Book
- Location
- Online
This book summarizes how the renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction and reviews the action of angiotensin converting enzyme inhibitors and AT1 receptor antagonists on reducing morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. ACEi and ARBS in Hypertension and Heart Failure is a highly practical reference reviewi…
- Available Online
- View e-Book
- Other Authors
- Perrone Filardi, Pasquale
- Other Authors
- International Society of Cardiovascular Pharmacotherapy
- Responsibility
- Pasquale Perrone Filardi, editor
- Alternate Title
- Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in hypertension and heart failure
- Place of Publication
- Cham
- Publisher
- Springer International Publishing : Imprint: Springer ; ISCP
- Date of Publication
- c2015
- Physical Description
- 1 online resource (x, 150 p. : 19 illus., 13 illus. in color)
- Series Title
- Current cardiovascular therapy
- ISBN
- 9783319097886
- 9783319097879 (print ed.)
- Subjects (MeSH)
- Angiotensin II Type 1 Receptor Blockers
- Angiotensin-Converting Enzyme Inhibitors - pharmacology
- Heart Failure - drug therapy
- Hypertension - drug therapy
- Renin-Angiotensin System
- Abstract
- This book summarizes how the renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction and reviews the action of angiotensin converting enzyme inhibitors and AT1 receptor antagonists on reducing morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. ACEi and ARBS in Hypertension and Heart Failure is a highly practical reference reviewing the evidence and providing a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It is written in an easy-to-follow format and with many illustrations to aid clarity and the assimilation of information. Each chapter is written by established authorities in their fields who are also experienced in explaining often complex concepts. The result is a unique book which is not only comprehensive but also clear and useful for the busy medical practitioner.
- Contents
- 1. Angiotensin Converting Enzyme Inhibitors and AT1 Antagonists for Treatment of Hypertension -- 2. ACE Inhibitor and Renin–Angiotensin System the Cornerstone of Therapy for Systolic Heart Failure -- 3. Impact of Chronic Kidney Disease and Diabetes Mellitus on Choice of Renin Angiotensin System: Inhibitors in Patients with Hypertension and Heart Failure -- 4. Target Organ Damage and RAAS Blockade.
- Format
- e-Book
- Location
- Online
Antiplatelet and anticoagulation therapy
https://libcat.nshealth.ca/en/permalink/provcat32336
Albert Ferro, David A. Garcia, editors.
--London:
Springer
, c2013.
- Available Online
- View e-Book
- Location
- Online
Aspirin has been in clinical use for over 100 years, making it one of the oldest commonly used drugs in medicine, and is now predominantly used as an antiplatelet agent. Major new antiplatelet drug classes have recently become available for the clinician that offer the promise of major improvements in the treatment and prevention of arterial thrombotic disease. In the field of anticoagulation, the vitamin K antagonists such as warfarin have not been available for as long as aspirin in the antip…
- Available Online
- View e-Book
- Other Authors
- Ferro, Albert
- Garcia, David A
- Responsibility
- Albert Ferro, David A. Garcia, editors
- Place of Publication
- London
- Publisher
- Springer
- Date of Publication
- c2013
- Physical Description
- 1 online resource (x, 247 p. : 37 ill., 26 ill. in color)
- Series Title
- Current cardiovascular therapy
- ISBN
- 9781447142973
- Subjects (MeSH)
- Arterial Occlusive Diseases - drug therapy
- Blood Coagulation Factor Inhibitors - therapeutic use
- Platelet Aggregation Inhibitors - therapeutic use
- Thrombosis - drug therapy
- Subjects (LCSH)
- Cardiology
- Abstract
- Aspirin has been in clinical use for over 100 years, making it one of the oldest commonly used drugs in medicine, and is now predominantly used as an antiplatelet agent. Major new antiplatelet drug classes have recently become available for the clinician that offer the promise of major improvements in the treatment and prevention of arterial thrombotic disease. In the field of anticoagulation, the vitamin K antagonists such as warfarin have not been available for as long as aspirin in the antiplatelet field, and have also had very little in the way of competition until recently; although a number of parenteral anticoagulants have been available, the vitamin K antagonists have been the only orally active anticoagulant drugs. The last few years have seen the arrival of new drug classes, the orally active direct thrombin inhibitors and factor Xa antagonists, which offer a number of advantages, but not without important drawbacks. In the face of these important advances in both antiplatelet and anticoagulant therapy, clinicians often feel confused, even overwhelmed, as to what is now available and which drugs are useful (and indicated) in which circumstances. Antiplatelet and Anticoagulant Therapy is designed with such people in mind. It is written in an easy-to-follow format and with many illustrations to aid clarity and the assimilation of information. Each chapter is written by established authorities in their fields who are also experienced in explaining often complex concepts. The result is a unique book which is not only comprehensive but also clear and useful for the busy medical practitioner.
- Contents
- Antiplatelet agents: current and novel -- Antiplatelet Drug Resistance and Variability in Response: The Role of Antiplatelet Therapy Monitoring -- Anticoagulant Drugs: Current and Novel -- Antithrombotic Treatment of Cardiovascular Disease -- Approaches to the Prophylaxis and Treatment of Venous and Cardiac Thromboembolic Disease -- Index.
- Format
- e-Book
- Location
- Online
Atrial Fibrillation and Percutaneous Coronary Intervention : A Case-based Guide to Oral Anticoagulation, Antiplatelet Therapy and Stenting
https://libcat.nshealth.ca/en/permalink/provcat41420
Andrea Rubboli, Gregory Y. H. Lip, editors.
--Cham:
Springer
, 2017.
- Available Online
- View e-Book
- Location
- Online
This book considers paradigmatic clinical cases in order to cast light on key issues relating to elective or emergency stent implantation and the use of oral anticoagulation (OAC) in patients with atrial fibrillation. The topics addressed include the optimal periprocedural antithrombotic treatment (uninterrupted vs interrupted OAC, intraprocedural use of heparin and glycoprotein IIb/IIIa inhibitors, etc.), the most appropriate type of stent (bare metal vs drug eluting vs "bioactive"), the optim…
- Available Online
- View e-Book
- Other Authors
- Rubboli, Andrea
- Lip, Gregory Y. H.
- Responsibility
- Andrea Rubboli, Gregory Y. H. Lip, editors
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- 2017
- Physical Description
- 1 online resource (viii, 212 pages) : 52 illus., 30 illus. in color
- ISBN
- 9783319424002
- 9783319423982 (print ed.)
- Subjects (MeSH)
- Anticoagulants - therapeutic use
- Atrial Fibrillation - drug therapy
- Atrial Fibrillation - surgery
- Percutaneous Coronary Intervention - methods
- Vitamin K - therapeutic use
- Abstract
- This book considers paradigmatic clinical cases in order to cast light on key issues relating to elective or emergency stent implantation and the use of oral anticoagulation (OAC) in patients with atrial fibrillation. The topics addressed include the optimal periprocedural antithrombotic treatment (uninterrupted vs interrupted OAC, intraprocedural use of heparin and glycoprotein IIb/IIIa inhibitors, etc.), the most appropriate type of stent (bare metal vs drug eluting vs "bioactive"), the optimal regimen (e.g., triple therapy of OAC, aspirin, and clopidogrel vs the combination of OAC and a single antiplatelet agent), and the most suitable duration of the antithrombotic treatment prescribed at discharge (1 vs 6-12 months). The case-based management recommendations will be of wide practical value in the current health care context, where percutaneous coronary intervention is available even to patients with relevant co-morbidities, such as those warranting long-term OAC, and the indications for OAC are much broader than in the past. The book will appeal especially to clinical and interventional cardiologists, internal medicine specialists, hematologists, and family physicians and will also be of interest to cardiology and internal medicine residents and fellows.
- Contents
- Atrial fibrillation on vitamin K-antagonists undergoing elective coronary artery stenting for stable effort angina -- Atrial fibrillation on NOAC (dabigatran) undergoing elective coronary artery stenting for stable effort angina -- Atrial fibrillation on vitamin K-antagonist undergoing urgent coronary stenting for non ST-elevation acute coronary syndrome -- Atrial fibrillation on NOAC (rivaroxaban) undergoing urgent coronary stenting for non ST-elevation acute coronary syndrome -- Atrial fibrillation on vitamin K-antagonist undergoing emergency primary coronary stenting for ST-elevation acute myocardial infarction -- Atrial fibrillation on NOAC (apixaban) undergoing emergency primary coronary stenting for ST-elevation acute myocardial infarction -- Atrial fibrillation early complicating acute coronary syndrome treated with coronary artery stenting -- New-onset atrial fibrillation in a stable patient with remote coronary artery stenting -- Urgent surgery early after coronary stenting in a patient with atrial fibrillation on triple therapy of warfarin, aspirin and clopidogrel -- Urgent surgery early after coronary stenting in a patjent with atrial fibrillation on triple therapy of NOAC (a factor Xa-inhibitor), aspirin and clopidogrel -- Major bleeding early after coronary stenting in a patient with atrial fibrillation on triple therapy of warfarin, aspirin and clopidogrel -- Major bleeding early after coronary stenting in a patient with atrial fibrillation on triple therapy of NOAC (dabigatran), aspirin and clopidogrel.
- Format
- e-Book
- Location
- Online
Autoimmune Thrombocytopenia
https://libcat.nshealth.ca/en/permalink/provcat41988
Yoji Ishida, Yoshiaki Tomiyama, editors.
--Singapore:
Springer
, 2017.
- Available Online
- View e-Book
- Location
- Online
This book provides a concise yet comprehensive summary of the current state of knowledge concerning the pathophysiology, differential diagnosis and treatment options that support day-to-day patient management. It reviews a variety of treatments including TOP-R antagonists, along with Syk inhibitor, which has recently proven to be effective, enabling readers to update and broaden their knowledge of the disease. Covering topics ranging from basic science to clinical practice, Autoimmune Thrombocy…
- Available Online
- View e-Book
- Other Authors
- Ishida, Yoji
- Tomiyama, Yoshiaki
- Responsibility
- Yoji Ishida, Yoshiaki Tomiyama, editors
- Place of Publication
- Singapore
- Publisher
- Springer
- Date of Publication
- 2017
- Physical Description
- 1 online resource (x, 229 pages) : 26 illus., 7 illus. in color
- ISBN
- 9789811041426
- 9789811041419 (print ed.)
- Subjects (MeSH)
- Purpura, Thrombocytopenic, Idiopathic
- Abstract
- This book provides a concise yet comprehensive summary of the current state of knowledge concerning the pathophysiology, differential diagnosis and treatment options that support day-to-day patient management. It reviews a variety of treatments including TOP-R antagonists, along with Syk inhibitor, which has recently proven to be effective, enabling readers to update and broaden their knowledge of the disease. Covering topics ranging from basic science to clinical practice, Autoimmune Thrombocytopenia will appeal to a wide readership, from medical interns and residents to clinicians and hematologists, offering them a thought-provoking, instructive and informative collection of cutting-edge works. Accordingly, readers will gain an overview of the autoimmune and other causes of the disease, and the book will serve as a foundation for new research directions that further our understanding of the pathophysiology and development of diagnosis and treatment options.
- Contents
- Part I: Introduction -- History of Immune Thrombocytopenia -- Part II: Basic Aspects of Platelet Biology -- Megakaryopoiesis and Thrombopoiesis -- Platelet Membrane Glycoproteins -- Part III: Epidemiology -- Epidemiology -- Part IV: Pathophysiology -- Autoantigens in ITP -- T-Cell Abnormalities -- Part V: Adult ITP -- ITP in Adults -- Part VI: Diagnosis -- Diagnosis in General -- Differential Diagnosis: Secondary ITP -- Differential Diagnosis: Hypoplastic Thrombocytopenia -- Differential Diagnosis: Congenital Macrothrombocytopenia -- Part VII: Treatment of Adult ITP -- Helicobacter pylori (H. pylori) Eradication -- Steroids -- High-Dose Immunoglobulin -- Splenectomy -- Rituximab -- Thrombopoietin Receptor Agonists -- Others (Syk Inhibitor and Other Medications) -- Transfusion -- Therapy in Pregnancy -- Part VIII: Child ITP -- Clinical Manifestations of ITP in Children -- Management and Treatment of Primary Immune Thrombocytopenia in Children.
- Format
- e-Book
- Location
- Online
Beta blockers
https://libcat.nshealth.ca/en/permalink/chpams35756
Nova Scotia Health Authority. Central Zone. Pharmacy Department.
Halifax, NS:
Nova Scotia Health Authority
, 2017.
- Pamphlet Number
- 0294
- Available Online
- View Pamphlet
This pamphlet will inform the reader about beta blockers and how to use them. The pamphlet explains what this type of medication is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medicines and foods to avoid. Symptoms that would need to be evaluated by a physician in the Emergency Department are listed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Central Zone. Pharmacy Department
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2017
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Adrenergic beta-Antagonists
- Subjects (LCSH)
- Adrenergic beta blockers
- Specialty
- Medications
- Abstract
- This pamphlet will inform the reader about beta blockers and how to use them. The pamphlet explains what this type of medication is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medicines and foods to avoid. Symptoms that would need to be evaluated by a physician in the Emergency Department are listed.
- Responsibility
- Prepared by: Pharmacy Department
- Pamphlet Number
- 0294
Bone Morphogenetic Proteins : Systems Biology Regulators
https://libcat.nshealth.ca/en/permalink/provcat41581
Slobodan Vukicevic, Kuber T. Sampath, editors.
--Cham:
Springer
, 2017.
- Available Online
- View e-Book
- Location
- Online
This book focuses on the salient features of the biology of Bone Morphogenetic Proteins and the advances in our understanding of their structure and function and of downstream signaling, as well as their governance in systems biology from bone and dentin to kidney, cancer, diabetes, iron homeostasis and angiogenesis, including rare musculoskeletal disorders. BMPs, also referred to as growth and differentiation factors, are members of the TGF-beta superfamily and are highly conserved from fruit …
- Available Online
- View e-Book
- Other Authors
- Vukicevic, Slobodan
- Sampath, Kuber T
- Responsibility
- Slobodan Vukicevic, Kuber T. Sampath, editors
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- 2017
- Physical Description
- 1 online resource (xii, 445 pages) : 43 illus., 32 illus. in color
- Series Title
- Progress in inflammation research
- ISBN
- 9783319475073
- 9783319475059 (print ed.)
- Abstract
- This book focuses on the salient features of the biology of Bone Morphogenetic Proteins and the advances in our understanding of their structure and function and of downstream signaling, as well as their governance in systems biology from bone and dentin to kidney, cancer, diabetes, iron homeostasis and angiogenesis, including rare musculoskeletal disorders. BMPs, also referred to as growth and differentiation factors, are members of the TGF-beta superfamily and are highly conserved from fruit flies to mammals and are responsible for the formation of practically every organ during embryo development and involved in adult tissue injury and repair. BMPs establish their extracellular gradient by interacting with their respective antagonists and regulate their function through SMAD-dependent down-stream signaling effector genes. This volume is aimed at scientists and professionals dealing with metabolic disorders, nutrition, systems biology diseases, rare musculoskeletal conditions, and disorders related to iron metabolism, including anemia of chronic disease, hereditary hemochromatosis and beta thalassemia.
- Contents
- Historical Perspective of Bone Morphogenetic Proteins -- The Systems Biology of Bone Morphogenetic Proteins -- Embryonic Skeletogenesis and Craniofacial Development -- BMP and BMP Regulation: Structure and Function -- Novel In Vitro Assay Models to Study Osteogenesis and Chondrogenesis for Human Skeletal Disorders -- Toward Advanced Therapy Medicinal Products (ATMPs) Combining Bone Morphogenetic Proteins (BMP) and Cells for Bone Regeneration -- BMP Signaling in Articular Cartilage Repair and Regeneration: Potential Therapeutic Opportunity for Osteoarthritis -- BMPs in Orthopaedic Medicine: Promises and Challenges -- Osteogrow: A Novel Bone Graft Substitute for Orthopedic Reconstruction -- Biology of Spine Fusion and Application of Osteobiologics in Spine Surgery -- BMPs in Dental Medicine: Promises and Challenges -- Bone Morphogenetic Protein-7 and Its Role in Acute Kidney Injury and Chronic Kidney Failure -- Bone Morphogenetic Protein Signaling in Pulmonary Arterial Hypertension -- BMP Signaling in Fibrodysplasia Ossificans Progressiva, a Rare Genetic Disorder of Heterotopic Ossification -- The Central Role of BMP Signaling in Regulating Iron Homeostasis -- BMPs in Inflammation -- Physiological and Pathological Consequences of Vascular BMP Signaling -- Bone Morphogenetic Proteins in the Initiation and Progression of Breast Cancer.
- Format
- e-Book
- Location
- Online
BRAF Targets in Melanoma : Biological Mechanisms, Resistance, and Drug Discovery
https://libcat.nshealth.ca/en/permalink/provcat39005
Ryan J. Sullivan, editor.
--New York, NY:
Springer
, c2015.
- Available Online
- View e-Book
- Location
- Online
This volume contains a collection of writings from the leaders in the fields of Molecular Biology and Melanoma Research which will begin to tell the ever-expanding story of the most recent findings, discoveries, and potential of BRAF-directed targets in melanoma. Recent research has shown that BRAF inhibitors are effective for a short period of time, but there is little hope that these drugs as single agents will lead to durable benefit in a majority of patients. Among scientists and researcher…
- Available Online
- View e-Book
- Other Authors
- Sullivan, Ryan J
- Responsibility
- Ryan J. Sullivan, editor
- Place of Publication
- New York, NY
- Publisher
- Springer
- Date of Publication
- c2015
- Physical Description
- 1 online resource (viii, 204 p. : 26 illus., 21 illus. in color)
- Series Vol.
- 82
- Series Title
- Cancer drug discovery and development
- ISBN
- 9781493921430
- 9781493921423 (print ed.)
- ISSN
- 2196-9906
- Subjects (MeSH)
- Melanoma - drug therapy
- Melanoma - genetics
- Molecular Targeted Therapy - methods
- Protein Kinase Inhibitors - therapeutic use
- Proto-Oncogene Proteins B-raf - antagonists & inhibitors
- Abstract
- This volume contains a collection of writings from the leaders in the fields of Molecular Biology and Melanoma Research which will begin to tell the ever-expanding story of the most recent findings, discoveries, and potential of BRAF-directed targets in melanoma. Recent research has shown that BRAF inhibitors are effective for a short period of time, but there is little hope that these drugs as single agents will lead to durable benefit in a majority of patients. Among scientists and researchers who work in drug discovery, there is a lot of interest in the development of molecularly targeted cancer agents. Namely, the identification of a molecular target, the selection of molecules which effectively inhibit this target. What is starkly different about the development of this class of compounds, however, is that the mechanism of action of these agents are not as straightforward as was once previously assumed and the mechanisms of resistance that tumor cells employ to evade complete destruction are unlike any that have been described before. These discoveries in addition to utilization of modern molecular biology techniques have led to a series of hypotheses regarding which other types of molecules could be used in combination with BRAF-inhibitors in hopes of revolutionizing the potential of therapeutics in melanoma.
- Contents
- 1. Melanoma: Historical Context -- 2. Melanoma Pathogenesis -- 3. Molecular Diagnostics and Tumor Mutational Analysis -- 4. Clinical Utility of BRAF-Targeted Therapy in Melanoma -- 5. The Ethics of Randomized Trials in Oncology -- 6. Parallel and Serial Blockade Strategies in BRAF-Mutant Melanoma -- 7. Targeting the Cell Cycle and p53 in Combination with BRAF-Directed Therapy -- 8. Combination BRAF-Directed Therapy and Immunotherapy -- 9. Moving Forward: Making BRAF-Targeted Therapy Better.
- Format
- e-Book
- Location
- Online
Calcium channel blockers
https://libcat.nshealth.ca/en/permalink/chpams35915
Nova Scotia Health Authority. QEII. Pharmacy Department.
Halifax, NS:
Nova Scotia Health Authority
, 2018.
- Pamphlet Number
- 0295
- Available Online
- View Pamphlet
Calcium channel blockers are used to treat chest pain and to control high blood pressure. A list of brand names is given. This pamphlet explains how to take calcium channel blockers, drugs and foods to avoid, warnings, possible side effects, and symptoms that you should mention to your doctor, nurse practitioner, or pharmacist.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Pharmacy Department
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2018
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Calcium Channel Blockers
- Chest Pain
- Hypertension
- Subjects (LCSH)
- Calcium--Antagonists
- Chest pain
- Hypertension
- Abstract
- Calcium channel blockers are used to treat chest pain and to control high blood pressure. A list of brand names is given. This pamphlet explains how to take calcium channel blockers, drugs and foods to avoid, warnings, possible side effects, and symptoms that you should mention to your doctor, nurse practitioner, or pharmacist.
- Responsibility
- Prepared by: Pharmacy Department
- Pamphlet Number
- 0295
Cardiac Drug Therapy
https://libcat.nshealth.ca/en/permalink/provcat39040
M. Gabriel Khan.
(8th ed.)
--Totowa, NJ:
Humana Press
, c2015.
- Available Online
- View e-Book
- Location
- Online
This book is an essential guide to the medical treatment of the cardiac patient and presents core principles of cardiovascular therapeutics as well as drug recommendations. Major classes of drugs are featured, including beta-blockers, ACE inhibitors, calcium antagonists, diuretics, and antiplatelet agents and unique insights into the controversies surrounding the use of specific drugs are explored, with answers given to the question: do beta blockers and diuretics really cause diabetes? Propert…
- Available Online
- View e-Book
- Author
- Khan, M. Gabriel
- Responsibility
- M. Gabriel Khan
- Edition
- 8th ed.
- Place of Publication
- Totowa, NJ
- Publisher
- Humana Press
- Date of Publication
- c2015
- Physical Description
- 1 online resource (xxxii, 791 p. : 44 illus., 6 illus. in color)
- Series Title
- Contemporary cardiology
- ISBN
- 9781617799624
- 9781617799617 (print ed.)
- ISSN
- 2196-8969
- Subjects (MeSH)
- Cardiovascular Agents - therapeutic use
- Heart Diseases - drug therapy
- Abstract
- This book is an essential guide to the medical treatment of the cardiac patient and presents core principles of cardiovascular therapeutics as well as drug recommendations. Major classes of drugs are featured, including beta-blockers, ACE inhibitors, calcium antagonists, diuretics, and antiplatelet agents and unique insights into the controversies surrounding the use of specific drugs are explored, with answers given to the question: do beta blockers and diuretics really cause diabetes? Properties, dosage, side effects, potential salutary benefits, and drawbacks on virtually all commercially available cardiac drugs are examined. This revised edition is thoroughly updated and addresses the entire spectrum of heart disorders, such as hypertension, angina, myocardial infarction, heart failure, arrhythmias, cardiac arrest, and dyslipidemias. New chapters include endocrine heart diseases, management of cardiomyopathies, and newer agents. In addition, topics such as cardiac drugs in pregnancy and lactation and drug interactions are covered. Cardiac Drug Therapy, Eighth Edition, is an authoritative and clinically relevant resource for cardiologists, cardiology fellows, and internists.
- Contents
- Beta-Blockers: The Cornerstone of Cardiac Drug Therapy -- Beta-Blocker Controversies -- Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers -- ACE Inhibitor Controversies -- Calcium Antagonists (Calcium Channel Blockers) -- Calcium Antagonist Controversies -- Diuretics -- Hypertension -- Hypertension Controversies -- Angina -- Myocardial Infarction -- Heart Failure -- Heart Failure Controversies -- Arrhythmias -- Cardiac Arrest -- Infective Endocarditis -- Dyslipidemias -- Endocrine Heart Diseases -- Antiplatelet Agents, Anticoagulants, Factor XA Inhibitors, and Thrombin Inhibitors -- Cardiac Drugs During Pregnancy and Lactation -- Drug Interactions -- Hallmark Clinical Trials -- Management of Cardiomyopathies -- Newer Agents.
- Format
- e-Book
- Publication Type
- Handbook
- Location
- Online
Central Pain Syndrome
https://libcat.nshealth.ca/en/permalink/provcat43278
Sergio Canavero, Vincenzo Bonicalzi.
(3rd fully revised and updated edition)
--Cham:
Springer
, c2018.
- Available Online
- View e-Book
- Location
- Online
This book sheds new light on central pain, a field that is largely obscured by lack of knowledge among pain professionals at all levels, including high-end pain centers. As a matter of fact, central pain, classified as a form of neuropathic pain, remains too often a scourge for those affected due to the ignorance of pain therapists worldwide and enduring misconceptions at the academic level. By weighing up the relevant evidence, the authors aim to remedy the situation by providing clear-cut, no…
- Available Online
- View e-Book
- Author
- Canavero, Sergio
- Other Authors
- Bonicalzi, Vincenzo
- Responsibility
- Sergio Canavero, Vincenzo Bonicalzi
- Edition
- 3rd fully revised and updated edition
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- c2018
- Physical Description
- 1 online resource (xi, 543 p.) : 5 illus., 4 illus. in color
- ISBN
- 9783319567655
- 9783319567648 (print ed.)
- 9783319567662 (print ed.)
- Subjects (MeSH)
- Central Nervous System Diseases - drug therapy
- Central Nervous System - physiopathology
- Pain - drug therapy
- Pain - physiopathology
- Pain Management - methods
- Specialty
- Pain Management
- Abstract
- This book sheds new light on central pain, a field that is largely obscured by lack of knowledge among pain professionals at all levels, including high-end pain centers. As a matter of fact, central pain, classified as a form of neuropathic pain, remains too often a scourge for those affected due to the ignorance of pain therapists worldwide and enduring misconceptions at the academic level. By weighing up the relevant evidence, the authors aim to remedy the situation by providing clear-cut, no-nonsense, unbiased and directly applicable clinical information. The clinically sound guidelines presented here are based on the authors' twenty years of treating patients and conducting research in the field. The book will be an invaluable guide for neurologists, neurosurgeons, anesthesiologists, pain therapists as well as physiotherapists.
- Contents
- Part I. Clinical Features -- Introduction -- Epidemiology -- Clinical Features -- Somatosensory Findings -- Central Pruritus -- Central Pain Allied Conditions (CPAC) -- Diagnosis -- Part II. Genesis -- Genesis -- Part III. Palliative Treatment -- Placebo, Nocebo and Expectancy -- Introduction to Palliative Treatment -- Gaba Agonists -- Anti-Glutamatergics -- Channel Blockers -- Brainstem Modulators -- Gabapentinoids -- Opioids and Antagonists -- Cannabinoids -- Sundry Molecules -- Non-Invasive Cortical Stimulation -- Invasive Cortical Stimulation -- Deep Brain Stimulation -- Spinal Cord Stimulation -- Non-Invasive Peripheral Nerve Stimulation -- Miscellaneous Neuromodulatory Techniques -- Intraspinal Drug Infusion -- Mind-Body Techniques -- Complementary Physical Therapies -- Complementary Drug Therapy -- Acupuncture and Reflexology -- Palliative Therapy: Guidelines -- Part IV. Curative Treatment -- Curative Surgery and other Experimental Approaches.
- Format
- e-Book
- Location
- Online
Clinical handbook of psychotropic drugs
https://libcat.nshealth.ca/en/permalink/provcat42420
Ric M. Procyshyn, principal editor ; Kalyna Z. Bezchlibnyk-Butler, co-editor ; J. Joel Jeffries, co-editor.
(22nd ed.)
--Boston, MA:
Hogrefe Publishing
, c2017.
- Call Number
- QV 77 C641 2017 REF
- Location
- Nova Scotia Hospital
- Cape Breton Regional
- Aberdeen Hospital
- Dickson Building
- Halifax Infirmary
- Sub-Location
- REFERENCE
The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals. Independent, unbiased. Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions) for a quick overview of treatment options. Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactio…
- Call Number
- QV 77 C641 2017 REF
- Other Authors
- Procyshyn, Ric M.
- Bezchlibnyk-Butler, Kalyna Z.
- Jeffries, J. Joel
- Responsibility
- Ric M. Procyshyn, principal editor ; Kalyna Z. Bezchlibnyk-Butler, co-editor ; J. Joel Jeffries, co-editor
- Edition
- 22nd ed.
- Alternate Title
- Psychotropic drugs
- CHPD
- Place of Publication
- Boston, MA
- Publisher
- Hogrefe Publishing
- Date of Publication
- c2017
- Physical Description
- 431 p.
- ISBN
- 9781616764968
- 1616764961
- Abstract
- The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals. Independent, unbiased. Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions) for a quick overview of treatment options. Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more - all you need to know for each class of drug. Potential interactions and side effects summarized in comparison charts. With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek. Clearly written patient information sheets available for download as printable PDF files.
- Contents
- Antidepressants -- Selective Serotonin Reuptake Inhibitors (SSRI) -- Norepinephrine Dopamine Reuptake Inhibitor (NDRI) -- Serotonin Norepinephrine Reuptake Inhibitor (SNRI) -- Serotonin-2 Antagonists/Reuptake Inhibitors (SARI) -- Serotonin-1A Agonist/Serotonin Reuptake Inhibitor -- Serotonin Stimulator/Serotonin Modulator -- Noradrenergic/Specific Serotonergic Antidepressants (NaSSA) -- Nonselective Cyclic Antidepressants -- Monoamine Oxidase Inhibitors -- Reversible Inhibitor of MAO-A (RIMA) -- Irreversible Monoamine Oxidase (A&B) Inhibitors (MAOIs) -- Irreversible MAO-B Inhibitor -- Effects of Antidepressants on Neurotransmitters/Receptors -- Pharmacological Effects of Antidepressants on Neurotransmitters/Receptors -- Frequency of Adverse Reactions to Antidepressants at Therapeutic Doses -- Antidepressant Doses and Pharmacokinetics -- Switching Antidepressants -- Antidepressant Augmentation Strategies -- Electroconvulsive Therapy (ECT) -- Bright Light Therapy (BLT) -- Repetitive Transcranial Magnetic Stimulation (rTMS) -- Antipsychotics -- "Second-Generation" Antipsychotics/SGAs -- "Third-Generation" Antipsychotic/TGA -- "First-Generation" Antipsychotics/FGAs -- Effects of Antipsychotics on Neurotransmitters/Receptors -- Pharmacological Effects of Antipsychotics on Neurotransmitters/Receptor Subtypes -- Relative Tolerability Profiles of Antipsychotics -- Frequency (%) of Adverse Reactions to Antipsychotics at Therapeutic Doses -- Antipsychotic Doses and Pharmacokinetics (Oral and Short-Acting Injections) -- Comparison of Long-Acting IM Antipsychotics -- Switching Antipsychotics -- Antipsychotic Augmentation Strategies -- Antipsychotic-Induced Extrapyramidal Side Effects and Their Management -- Extrapyramidal Adverse Effects of Antipsychotics -- Treatment Options for Extrapyramidal Side Effects -- Effects on Extrapyramidal Symptoms -- Comparison of Agents for Treating Acute Extrapyramidal Side Effects -- Doses and Pharmacokinetics of Agents for Treating Acute Extrapyramidal Side Effects -- Anxiolytic (Antianxiety) Agents -- Benzodiazepines -- Comparison of the Benzodiazepines -- Buspirone -- Hypnotics/Sedatives -- L-Tryptophan -- Comparison of Hypnotics/Sedatives -- Mood Stabilizers -- Lithium -- Anticonvulsants -- Comparison of Anticonvulsants -- Frequency of Adverse Reactions to Mood Stabilizers at Therapeutic Doses -- Drugs for ADHD -- Psychostimulants -- Atomoxetine -- Comparison of Drugs for ADHD -- a2 agonists -- Augmentation Strategies in ADHD -- Drugs for Treatment of Dementia -- Cholinesterase Inhibitors -- Memantine -- Comparison of Drugs for Treatment of Dementia -- Sex-Drive Depressants -- Comparison of Sex-Drive Depressants -- Drugs of Abuse -- Alcohol -- Stimulants -- Hallucinogens -- Opioids -- Inhalants/Aerosols -- Gamma-hydroxybutyrate (GHB)/Sodium Oxybate -- Flunitrazepam (Rohypnol) -- Nicotine/Tobacco -- Treatment of Substance Use Disorders -- Acamprosate -- Disulfiram -- Naltrexone -- Buprenorphine -- Methadone -- Pharmacotherapy for Nicotine/Tobacco Use Dependence -- Unapproved Treatments of Psychiatric Disorders -- Adrenergic Agents -- Dopaminergic Agents -- GABA Agents/Anticonvulsants -- Hormones -- NMDA Agents -- Miscellaneous -- Natural Health Products -- Ginkgo Biloba -- Inositol -- Kava Kava -- Melatonin -- Omega-3 Polyunsaturated Fatty Acids -- S-Adenosyl-L-methionine (SAMe) -- St. John's Wort -- Valerian -- Vitamins -- Pharmacogenomic Information for Common Psychotropic Drugs -- Antidepressants -- Antipsychotics -- Mood Stabilizers -- Drugs for Treatment of Dementia -- Opiate Receptor Ligands, Alcohol, Interferon -- Glossary -- Drug use in pregnancy and effects on breast milk -- Patient information sheets -- Appendix: Neuroscience-based nomenclature (NbN) -- Index of drugs.
- Format
- Book
- Publication Type
- Handbook
- Location
- Nova Scotia Hospital
- Cape Breton Regional
- Aberdeen Hospital
- Dickson Building
- Halifax Infirmary
- Sub-Location
- REFERENCE
- Copies
- 5
- Loan Period
- In library use
Clinical handbook of psychotropic drugs
https://libcat.nshealth.ca/en/permalink/provcat42494
Ric M. Procyshyn, principal editor ; Kalyna Z. Bezchlibnyk-Butler, co-editor ; J. Joel Jeffries, co-editor.
(22nd ed.)
--Boston, MA:
Hogrefe Publishing
, c2017.
- Call Number
- QV 77 C641 2017
- Location
- Yarmouth Regional Hospital
The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals. Independent, unbiased. Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions) for a quick overview of treatment options. Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactio…
- Call Number
- QV 77 C641 2017
- Other Authors
- Procyshyn, Ric M.
- Bezchlibnyk-Butler, Kalyna Z.
- Jeffries, J. Joel
- Responsibility
- Ric M. Procyshyn, principal editor ; Kalyna Z. Bezchlibnyk-Butler, co-editor ; J. Joel Jeffries, co-editor
- Edition
- 22nd ed.
- Alternate Title
- Psychotropic drugs
- CHPD
- Place of Publication
- Boston, MA
- Publisher
- Hogrefe Publishing
- Date of Publication
- c2017
- Physical Description
- 431 p.
- ISBN
- 9781616764968
- 1616764961
- Abstract
- The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals. Independent, unbiased. Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions) for a quick overview of treatment options. Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more - all you need to know for each class of drug. Potential interactions and side effects summarized in comparison charts. With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek. Clearly written patient information sheets available for download as printable PDF files.
- Contents
- Antidepressants -- Selective Serotonin Reuptake Inhibitors (SSRI) -- Norepinephrine Dopamine Reuptake Inhibitor (NDRI) -- Serotonin Norepinephrine Reuptake Inhibitor (SNRI) -- Serotonin-2 Antagonists/Reuptake Inhibitors (SARI) -- Serotonin-1A Agonist/Serotonin Reuptake Inhibitor -- Serotonin Stimulator/Serotonin Modulator -- Noradrenergic/Specific Serotonergic Antidepressants (NaSSA) -- Nonselective Cyclic Antidepressants -- Monoamine Oxidase Inhibitors -- Reversible Inhibitor of MAO-A (RIMA) -- Irreversible Monoamine Oxidase (A&B) Inhibitors (MAOIs) -- Irreversible MAO-B Inhibitor -- Effects of Antidepressants on Neurotransmitters/Receptors -- Pharmacological Effects of Antidepressants on Neurotransmitters/Receptors -- Frequency of Adverse Reactions to Antidepressants at Therapeutic Doses -- Antidepressant Doses and Pharmacokinetics -- Switching Antidepressants -- Antidepressant Augmentation Strategies -- Electroconvulsive Therapy (ECT) -- Bright Light Therapy (BLT) -- Repetitive Transcranial Magnetic Stimulation (rTMS) -- Antipsychotics -- "Second-Generation" Antipsychotics/SGAs -- "Third-Generation" Antipsychotic/TGA -- "First-Generation" Antipsychotics/FGAs -- Effects of Antipsychotics on Neurotransmitters/Receptors -- Pharmacological Effects of Antipsychotics on Neurotransmitters/Receptor Subtypes -- Relative Tolerability Profiles of Antipsychotics -- Frequency (%) of Adverse Reactions to Antipsychotics at Therapeutic Doses -- Antipsychotic Doses and Pharmacokinetics (Oral and Short-Acting Injections) -- Comparison of Long-Acting IM Antipsychotics -- Switching Antipsychotics -- Antipsychotic Augmentation Strategies -- Antipsychotic-Induced Extrapyramidal Side Effects and Their Management -- Extrapyramidal Adverse Effects of Antipsychotics -- Treatment Options for Extrapyramidal Side Effects -- Effects on Extrapyramidal Symptoms -- Comparison of Agents for Treating Acute Extrapyramidal Side Effects -- Doses and Pharmacokinetics of Agents for Treating Acute Extrapyramidal Side Effects -- Anxiolytic (Antianxiety) Agents -- Benzodiazepines -- Comparison of the Benzodiazepines -- Buspirone -- Hypnotics/Sedatives -- L-Tryptophan -- Comparison of Hypnotics/Sedatives -- Mood Stabilizers -- Lithium -- Anticonvulsants -- Comparison of Anticonvulsants -- Frequency of Adverse Reactions to Mood Stabilizers at Therapeutic Doses -- Drugs for ADHD -- Psychostimulants -- Atomoxetine -- Comparison of Drugs for ADHD -- a2 agonists -- Augmentation Strategies in ADHD -- Drugs for Treatment of Dementia -- Cholinesterase Inhibitors -- Memantine -- Comparison of Drugs for Treatment of Dementia -- Sex-Drive Depressants -- Comparison of Sex-Drive Depressants -- Drugs of Abuse -- Alcohol -- Stimulants -- Hallucinogens -- Opioids -- Inhalants/Aerosols -- Gamma-hydroxybutyrate (GHB)/Sodium Oxybate -- Flunitrazepam (Rohypnol) -- Nicotine/Tobacco -- Treatment of Substance Use Disorders -- Acamprosate -- Disulfiram -- Naltrexone -- Buprenorphine -- Methadone -- Pharmacotherapy for Nicotine/Tobacco Use Dependence -- Unapproved Treatments of Psychiatric Disorders -- Adrenergic Agents -- Dopaminergic Agents -- GABA Agents/Anticonvulsants -- Hormones -- NMDA Agents -- Miscellaneous -- Natural Health Products -- Ginkgo Biloba -- Inositol -- Kava Kava -- Melatonin -- Omega-3 Polyunsaturated Fatty Acids -- S-Adenosyl-L-methionine (SAMe) -- St. John's Wort -- Valerian -- Vitamins -- Pharmacogenomic Information for Common Psychotropic Drugs -- Antidepressants -- Antipsychotics -- Mood Stabilizers -- Drugs for Treatment of Dementia -- Opiate Receptor Ligands, Alcohol, Interferon -- Glossary -- Drug use in pregnancy and effects on breast milk -- Patient information sheets -- Appendix: Neuroscience-based nomenclature (NbN) -- Index of drugs.
- Format
- Book
- Publication Type
- Handbook
- Location
- Yarmouth Regional Hospital
- Loan Period
- 3 weeks use
Comprehensive treatment of chronic pain by medical, interventional, and integrative approaches : the American Academy of Pain Medicine textbook on patient management
https://libcat.nshealth.ca/en/permalink/provcat32560
Timothy R. Deer, editor-in-chief ; Michael S. Leong, associate editor-in-chief ; Asokumar Buvanendran, Vitaly Gordin, Philip S. Kim ... [et al.], editors.
--New York, NY:
Springer
, c2013.
- Available Online
- View e-Book
- Location
- Online
Edited by master clinician-experts appointed by the American Academy of Pain Medicine, this is a state-of-the-art multidisciplinary textbook covering medical, interventional, and integrative approaches to the treatment and management of pain. It is designed as a practical and comprehensive primary reference for busy physicians and is also an up-to-date resource for preparing for certification examinations in pain medicine. Written and edited by world-class authorities -- 'Key Points' preview c…
- Available Online
- View e-Book
- Corporate Author
- American Academy of Pain Medicine
- Other Authors
- Deer, Timothy R
- Responsibility
- Timothy R. Deer, editor-in-chief ; Michael S. Leong, associate editor-in-chief ; Asokumar Buvanendran, Vitaly Gordin, Philip S. Kim ... [et al.], editors
- Place of Publication
- New York, NY
- Publisher
- Springer
- Date of Publication
- c2013
- Physical Description
- 1 online resource (xxvii, 1104 p. : 412 ill., 233 ill. in color)
- ISBN
- 9781461415602
- Subjects (MeSH)
- Chronic Pain - therapy
- Integrative Medicine
- Pain Management
- Subjects (LCSH)
- Medicine
- Anesthesiology
- Neurology
- Pain medicine
- Abstract
- Edited by master clinician-experts appointed by the American Academy of Pain Medicine, this is a state-of-the-art multidisciplinary textbook covering medical, interventional, and integrative approaches to the treatment and management of pain. It is designed as a practical and comprehensive primary reference for busy physicians and is also an up-to-date resource for preparing for certification examinations in pain medicine. Written and edited by world-class authorities -- 'Key Points' preview contents of each chapter -- Leading edge medical topics, such as monitoring opioid use and abuse, and the emerging role of cannabinoids in pain treatment -- Expert guidance on full range of interventional techniques -- Clinical anatomy and physiology for the interventionist – Behavioral dimensions of the experience and management of pain -- Integrative approaches for treating the 'whole person' -- Legal issues, such as failure to treat pain -- First-hand patient accounts.
- Contents
- Part I. Medical Approaches -- 1. A Survey of Systems Involved in Nociceptive Processing -- 2. Pharmacogenomics of Pain Management -- 3. Nonsteroidal Anti-inflammatory Drugs -- 4. The Role of Antidepressants in the Treatment of Chronic Pain -- 5. Anticonvulsant Medications for Treatment of Neuropathic and 'Functional' Pain -- 6. NMDA Receptor Antagonists in the Treatment of Pain -- 7. Role of Muscle Relaxants in the Treatment of Pain -- 8. Topical Analgesics -- 9. Sleep Aids -- 10. Clinical Use of Opioids -- 11. Opioid Adverse Effects and Opioid-Induced Hypogonadism -- 12. Acute Management of the Opioid-Dependent Patient -- 13. Opioids and the Law -- 14. Methadone for Chronic Pain -- 15. Toxicology Screening for Opioids -- 16. Monitoring Drug Use and Abuse: The Evolution of a Paradigm -- 17. Polypharmacy and Drug Interaction -- 18. Role of Cannabinoids in Pain Management -- 19. The Future of Pain Pharmacotherapy -- Part II. Interventional Approaches: Anatomy and Physiology of Pain -- 20. Neuroanatomy and Neurophysiology of Pain -- 21. Spinal Targets for Interventional Pain Management -- 22. Functional Anatomy and Imaging of the Spine -- Part III. Interventional Approaches: Neural Blockade and Neurolysis Blocks -- 23. Local Anesthetics -- 24. Neurolytic Agents -- 25. Cryoanalgesia -- 26. Radiofrequency: Conventional and Pulsed -- 27. Atlanto-Axial and Atlanto-Occipital Joints Injection in the Treatment of Headaches and Neck Pain -- 28. Sphenopalatine Ganglion Block -- 29. Occipital Nerve Block -- 30. Neural Blockade for Trigeminal Neuralgia -- 31. Glossopharyngeal Nerve Block -- 32. Cervical Plexus Block -- 33. Stellate Ganglion Blockade -- 34. Epidural (Cervical, Thoracic, Lumbar, Caudal) Block/Injections -- 35. Transforaminal Epidural Steroid Injections -- 36. Facet Injections and Radiofrequency Denervation -- 37. Intercostal Nerve Blocks -- 38. Intrapleural Catheters -- 39. Epidural Lysis of Adhesions: Percutaneous and Endoscopic Techniques -- 40. Thoracic and Lumbar Sympathetic Nerve Block and Neurolysis -- 41. Celiac Plexus, Splanchnic Nerve Block, and Neurolysis -- 42. Superior Hypogastric Plexus, Ganglion Impar Blocks, and Neurolysis -- 43. Peripheral Neurolysis -- 44. Central Neuraxial Neurolysis -- 45. Provocative Discography -- 46. Brachial Plexus Block -- 47. Suprascapular Nerve Block -- 48. Intradiscal Annuloplasty for the Treatment of Discogenic Pain -- 49. Percutaneous Disc Decompression -- 50. The Racz Procedure: Lysis of Epidural Adhesions (Percutaneous Neuroplasty) -- 51. Sacroiliac Joint Injection and Radiofrequency Denervation -- 52. Vertebral Augmentation: Vertebroplasty and Kyphoplasty -- 53. Piriformis Injection -- 54. Botulinum Toxin in the Management of Painful Conditions -- 55. Emerging Imaging Tools for Interventional Pain -- Part IV. Interventional Approaches: Neuromodulation -- 56. A History of Neurostimulation -- 57. Stimulation of the Peripheral Nerve and Peripheral Nerve Field -- 58. Spinal Cord Stimulation -- 59. Brain Stimulation for Pain -- 60. Motor Cortex Stimulation -- 61. Intrathecal Drug Delivery for Control of Pain -- 62. Clinical Applications of Neuromodulation: Radicular Pain and Low Back Pain -- 63. Clinical Applications of Neuromodulation: Neurostimulation for Complex Regional Pain Syndrome -- 64. Clinical Applications of Neuromodulation: Section on Angina and Peripheral Vascular Disease -- 65. Clinical Applications of Neuromodulation: Spinal Cord Stimulation for Abdominal Pain -- 66. Cost-Effectiveness of Interventional Techniques -- 67. Neurosurgical Techniques for Pain Management -- 68. Spinal Cord Stimulation in the Treatment of Postherpetic Neuralgia -- 69. Complications of Interventional Pain Management Techniques -- Part V. Integrative Approaches -- 70. Pain as a Perceptual Experience -- 71. Neuroplasticity, Sensitization, and Pain -- 72. Muscle Pain Treatment -- 73. Addictive Disorders and Pain -- 74. The 'Five-Minute' Mental Status Examination of Persons with Pain -- 75. The Psychological Assessment of Patients with Chronic Pain -- 76. Psychological Therapies -- 77. Billing Psychological Services for Patients with Chronic Pain -- 78. Hypnosis and Pain Control -- 79. Acupuncture -- 80. Manual Therapies -- 81. Treatment of Chronic Painful Musculoskeletal Injuries and Diseases with Regenerative Injection Therapy (RIT): Regenerative Injection Therapy Principles and Practice -- 82. Interdisciplinary Functional Restoration and Pain Programs -- 83. Pain and Spirituality -- 84. Pain Disparity: Assessment and Traditional Medicine -- 85. Sleep and Chronic Pain -- 86. Empowerment: A Pain Caregiver's Perspective -- 87. Patient and Caregiver's Perspective -- 88. Pain Medicine in Older Adults: How Should It Differ? -- 89. Pain Medicine and Primary Care: The Evolution of a Population-Based Approach to Chronic Pain as a Public Health Problem -- 90. Pain Care Beyond the Medical Practice Office: Utilizing Patient Advocacy, Education, and Support Organizations -- 91. Neonatal Pain -- 92. Assessing Disability in the Pain Patient -- 93. The Double Effect: In Theory and in Practice -- 94. Failure to Treat Pain -- Index.
- Format
- e-Book
- Location
- Online
Deer's Treatment of Pain : An Illustrated Guide for Practitioners
https://libcat.nshealth.ca/en/permalink/provcat44680
Timothy R. Deer, Jason E. Pope, Tim J. Lamer, David Provenzano, editors.
--Cham:
Springer
, c2019.
- Available Online
- View e-Book
- Location
- Online
Designed and written by a team of clinically established academics, this is a unique book that is an excellent manual for physicians practicing pain medicine or treating pain in neurosurgery, orthopedic, neurology, or family practice clinics. As a practical resource, this book is written to be more accessible to the reader and is designed to be more clinically-focused and useful in day-to-day practice. This 102 chapter volume is divided into seven separate sections: Anatomy and Physiology of Pa…
- Available Online
- View e-Book
- Other Authors
- Deer, Timothy R.
- Pope, Jason E.
- Lamer, Tim J.
- Provenzano, David
- Responsibility
- Timothy R. Deer, Jason E. Pope, Tim J. Lamer, David Provenzano, editors
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- c2019
- Physical Description
- 1 online resource (xxvi, 854 p.) : 339 illus., 222 illus. in color
- ISBN
- 9783030122812
- 9783030122805 (Print ed.)
- 9783030122829 (Print ed.)
- 9783030122836 (Print ed.)
- Subjects (MeSH)
- Analgesics - therapeutic use
- Electric Stimulation Therapy
- Nerve Block
- Pain Management - methods
- Specialty
- Pain Management
- Abstract
- Designed and written by a team of clinically established academics, this is a unique book that is an excellent manual for physicians practicing pain medicine or treating pain in neurosurgery, orthopedic, neurology, or family practice clinics. As a practical resource, this book is written to be more accessible to the reader and is designed to be more clinically-focused and useful in day-to-day practice. This 102 chapter volume is divided into seven separate sections: Anatomy and Physiology of Pain, Psychology of Pain, Pharmacological Treatment of Pain, Interventional Treatment of Pain, Adjuvant Therapies for Pain and Suggested Reading. The calculated organization of this book is supplemented by key photos, drawings and a self-assessment of four key questions at the end of each chapter -- thus making it an indispensable, pragmatic resource that will benefit anyone working in the pain management field. Deer's Treatment of Pain: An Illustrated Guide for Practitioners contains pearls for improving knowledge and improving one’s practice as a physician.
- Contents
- Part I: INTRODUCTION -- The Disease-Based Treatment of Pain -- Algorithms of Pain Treatment -- The Opioid Epidemic and the Need for a Pain Strategy -- Part II: ANATOMY AND PHYSIOLOGY OF PAIN -- Nerve Function and Neurons -- Peripheral Nerve Anatomy -- Spinal Cord Anatomy -- Anatomy of the Brain and Brainstem -- Mediators of Pain and Pain Processing -- Taxonomy of Pain -- Pain Relieving Mechanisms in Neuromodulation -- Part III: PSYCHOLOGY OF PAIN -- The Normal Response to Pain -- Pain and Suffering -- Social Impact of Pain Response -- Role of Religion and Spirituality in the Patient Pain Experience -- Anxiety and Depression in Patients with Chronic Pain -- Psychological Treatments to Improve Outcomes -- Psychological Evaluation for Those Receiving Devices for the Treatment Of Pain -- Part IV: PHARMACOLOGICAL TREATMENT OF PAIN -- Acetaminophen and Nonsteroidal Anti-inflammatory Drugs -- Anticonvulsants in the Treatment of Pain -- Botulinum Toxin -- Sodium Channel Antagonists -- Anti-Spasmodics and Muscle Relaxants -- Antidepressants in Pain Management -- Ketamine and NMDA-Receptor Antagonists -- Novel Analgesics -- Injectable Corticosteroids -- Topical Therapies -- Opioids for Chronic Non-Cancer Pain -- Opioids for Cancer Pain and Hospice Care -- Pharmacogenetics and Pharmacogenomics of Pain Treatment -- Part V: INTERVENTIONAL TREATMENT OF PAIN -- Radiation Safety -- Radiofrequency Ablation -- Basic Science of Radiofrequency -- Cryotherapy -- Chemodenervation: Neurolytic Blockade and Potent Neurotoxins for the Treatment of Cancer Pain -- Blockade of the Nerves of the Head and Face -- Ganglion Blocks of Head and Face -- Destructive procedures of the Head and Face -- 39. Interlaminar Approach for Cervical Epidural Steroid Injection -- Cervical Transforaminal Epidural Injections -- Diagnostic Cervical Nerve Root Blocks -- Cervical Facet Joint Injection and Medial Branch Blocks -- Cervical Facet Radiofrequency Neurotomy -- Intercostal Nerve Block -- Intercostal Nerve Block -- Thoracic Interlaminar Epidural Steroid Injection -- Thoracic Facet and Medial Branch Blocks -- Radiofrequency Ablation in the Thoracic Spine -- Lumbar Interlaminar Epidural Injection -- Lumbar Transforaminal Epidural Corticosteroid Injections -- Lumbar Facet and Medial Branch Block -- Sacroiliac Joint Injection -- Sacroiliac Joint Radiofrequency -- Sacroiliac Joint Fusion -- Caudal Epidural Injection -- Stellate Ganglion Block -- Lumbar Sympathetic Block -- Celiac Plexus Block and Superior Hypogastric Plexus Block -- Ganglion Impar Block -- Large Joint Injections -- Part VI: NEUROMODULATION -- Deep Brain Stimulation -- Motor Cortex Stimulation -- Occipital Nerve Stimulation -- Sphenopalatine Ganglion Block -- Percutaneous Cervical Spinal Cord Stimulation -- Surgical Leads for the Cervical Spine -- Dorsal Root Ganglion Stimulation–Cervical Spine -- Percutaneous Thoracic Neurostimulation for Chronic Pain -- Surgical Lead for the Thoracic Spine -- Percutaneous Lumbar Stimulation -- Thoracic and Lumbar Dorsal Root Ganglion Spinal Stimulation -- Percutaneous Sacral Nerve Stimulation -- Sacral Dorsal Root Ganglion Spinal Stimulation -- Peripheral Nerve Stimulation -- Stimulation Methods and Device Choices: Dorsal Root Ganglion Stimulation, Spinal Cord Stimulation, and Peripheral Nerve Stimulation -- Patient Selection -- Wound Closure and Surgical Healing -- Complications of Neuromodulation -- PART 7: NEUROAXIAL THERAPIES -- Intrathecal Pharmacology -- Patient Selection -- Intrathecal Device Considerations -- Intrathecal Agents and Algorithms: Review of PACC 2012 and 2017 Guidelines and Beyond -- Implantable Drug Delivery Systems for Cancer Pain and End Of Life Care -- Intrathecal Drug Delivery Systems for Chronic Non-Cancer Pain -- IDDS For Movement Disorders -- Ziconitide for Intrathecal Use -- PART 8: REGENERATIVE THERAPIES FOR CHRONIC PAIN -- Scientific Bases of PRP Therapy -- Scientific Basis for Stem Cell Therapy -- Stem Cells -- Regenerative Therapies for Chronic Intradiscal Pain -- PRP Therapies (Tendons, Joints, Spine) -- PART 9: INTRADISCAL AND MINIMALLY INVASIVE STRUCTURAL SURGERIES -- Discography -- Endoscopic Discectomy -- Vertebral Augmentation for Painful Vertebral Compression Fractures -- Vertebroplasty and other methods of vertebral augmentation -- Minimally Invasive Lumbar Decompression -- Interspinous Process Spacers for Indirect Lumbar Decompression -- PART 10. REHABILITATION AND ADJUVANT THERAPIES FOR PAIN -- Physical Therapy -- Acupuncture -- PART 11. ADMINISTRATIVE CONSIDERATIONS -- Cybersecurity of Medical Devices: Past, Present, and Future -- Coding and Billing -- Medicare Payment Quality Measures.
- Format
- e-Book
- Location
- Online
Diabetic Retinopathy : Current Pharmacologic Treatment and Emerging Strategies
https://libcat.nshealth.ca/en/permalink/provcat41979
Michael W. Stewart.
--Singapore:
Adis
, 2017.
- Available Online
- View e-Book
- Location
- Online
A well-illustrated and comprehensive analysis of the treatment of diabetic retinopathy, this book covers current treatment options and guidelines, whilst also providing a detailed discussion of emerging therapeutic targets. Existing therapeutic options are covered in depth, with a major focus on anti-vascular endothelial growth factor drugs and sustained release corticosteroids, including a review of trial results supporting current treatment guidelines. The use of agents off-label is also disc…
- Available Online
- View e-Book
- Author
- Stewart, Michael W
- Responsibility
- Michael W. Stewart
- Place of Publication
- Singapore
- Publisher
- Adis
- Date of Publication
- 2017
- Physical Description
- 1 online resource (xiii, 268 pages) : 61 illus., 48 illus. in color
- ISBN
- 9789811035098
- 9789811035081 (print ed.)
- Subjects (MeSH)
- Angiogenesis Inhibitors - therapeutic use
- Diabetic Retinopathy - drug therapy
- Diabetic Retinopathy - physiopathology
- Vascular Endothelial Growth Factor A - antagonists & inhibitors
- Abstract
- A well-illustrated and comprehensive analysis of the treatment of diabetic retinopathy, this book covers current treatment options and guidelines, whilst also providing a detailed discussion of emerging therapeutic targets. Existing therapeutic options are covered in depth, with a major focus on anti-vascular endothelial growth factor drugs and sustained release corticosteroids, including a review of trial results supporting current treatment guidelines. The use of agents off-label is also discussed. Controversial topics are discussed in detail with an emphasis on helping the reader make informed decisions, particularly when treating patients for which several treatment approaches may be appropriate because trial data does not clearly define the best option. Emerging therapeutic areas are evaluated, as work continues to identify agents that produce superior morphologic responses and visual acuity gains by targeting other molecules that contribute to diabetic retinopathy. Promising new drugs, targets and delivery systems are identified, and their development analysed.
- Contents
- 1. Diabetes and Diabetic Retinopathy: Overview Of A World-Wide Epidemic -- 2. The Diabetic Retina: Anatomy and Pathophysiology -- 3. Treatment of Diabetic Retinopathy: A Historical Perspective -- 4. Targeting Vascular Endothelial Growth Factor -- 5. Corticosteroids: Targeting Multiple Cytokines and Chemokines -- 6. Current Treatment Recommendations -- 7. Vitreolysis: Targeting the Vitreoretinal Interface -- 8. Investigational Medications -- 9. Safety Considerations of Pharmacotherapy -- 10. Socioeconomic Cost of Diabetic Retinopathy and Therapy.
- Format
- e-Book
- Location
- Online
Diagnosis and Management of Pulmonary Hypertension
https://libcat.nshealth.ca/en/permalink/provcat39027
James R. Klinger, Robert P. Frantz, editors.
--New York, NY:
Springer New York : Imprint: Humana Press
, c2015.
- Available Online
- View e-Book
- Location
- Online
This book provides an overview of pulmonary hypertensive diseases, the current understanding of their pathobiology, and a contemporary approach to diagnosis and treatment. It discusses the definition and classification of these disorders and the epidemiology of pulmonary arterial hypertension (PAH); explores the approach to diagnosis and evaluation via methods such as echocardiography, right heart catheterization, and cardiopulmonary exercise testing; describes the major drug classes used to tr…
- Available Online
- View e-Book
- Other Authors
- Klinger, James R
- Frantz, Robert P
- Responsibility
- James R. Klinger, Robert P. Frantz, editors
- Place of Publication
- New York, NY
- Publisher
- Springer New York : Imprint: Humana Press
- Date of Publication
- c2015
- Physical Description
- 1 online resource (xiv, 474 p. : 92 illus., 47 illus. in color)
- Series
- Respiratory Medicine
- Series Vol.
- 12
- Series Title
- Respiratory medicine (New York, N.Y.)
- ISBN
- 9781493926367
- 9781493926350 (print ed.)
- ISSN
- 2197-7372
- Subjects (MeSH)
- Hypertension, Pulmonary - diagnosis
- Hypertension, Pulmonary - therapy
- Disease Management
- Abstract
- This book provides an overview of pulmonary hypertensive diseases, the current understanding of their pathobiology, and a contemporary approach to diagnosis and treatment. It discusses the definition and classification of these disorders and the epidemiology of pulmonary arterial hypertension (PAH); explores the approach to diagnosis and evaluation via methods such as echocardiography, right heart catheterization, and cardiopulmonary exercise testing; describes the major drug classes used to treat PAH and the cell signaling pathways that they target as well as adjunct and investigative therapies; and highlights special situations that are particularly challenging in the management of PAH. Written by experts in their respective fields, Diagnosis and Management of Pulmonary Hypertension is a valuable resource for pulmonologists, cardiologists, and practitioners in internal medicine and critical care.
- Contents
- The Pulmonary Circulation -- Epidemiology and Disease Classification of Pulmonary Hypertension -- Pathogenesis of Pulmonary Arterial Hypertension -- Hypoxic Pulmonary Hypertension -- Pulmonary Hypertension In Chronic Heart And Lung Disease -- Chronic Thromboembolic Pulmonary Hypertension -- Schistosomiasis- Associated Pulmonary Arterial Hypertension -- Approach to the Patient with Elevated Pulmonary Arterial Pressure -- Echocardiography -- Pulmonary Hemodynamics and Right Heart Catheterization -- Cardiopulmonary Exercise Testing in Pulmonary Hypertension -- Adjunct Therapy and Calcium Channel Blockers -- Prostacyclin Therapy for Pulmonary Arterial Hypertension -- Endothelin Receptor Antagonists -- Modulation Of cGMP Synthesis And Metabolism -- Combination Therapy for the Treatment of Pulmonary Arterial Hypertension -- Investigative Therapies in Pulmonary Arterial Hypertension -- Pulmonary Hypertension In Critically Ill Patients -- Perioperative Management of Pulmonary Hypertension.
- Format
- e-Book
- Location
- Online
Epigenetic therapy of cancer : preclinical models and treatment approaches
https://libcat.nshealth.ca/en/permalink/provcat33709
Michael Lübbert, Peter A. Jones, editors.
--Heidelberg:
Springer
, c2014.
- Available Online
- View e-Book
- Location
- Online
The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders such as myeloid leukemias and preleukemias (myelodysplasias) is now being translated into treatment approaches that target the epigenetic defects pharmacologically. Such approaches include reactivation of tumor suppressor genes and other antiproliferative genes by reversal of DNA hypermethylation through azanucleosides, and use of HDAC inhibitors to reverse gene silencing mediated by chim…
- Available Online
- View e-Book
- Other Authors
- Lübbert, Michael
- Jones, P. A
- Responsibility
- Michael Lübbert, Peter A. Jones, editors
- Place of Publication
- Heidelberg
- Publisher
- Springer
- Date of Publication
- c2014
- Physical Description
- 1 online resource (x, 325 pages)
- ISBN
- 9783642384042 (electronic bk.)
- 9783642384035
- Subjects (MeSH)
- DNA Methylation - genetics
- Epigenesis, Genetic - physiology
- Genetic therapy
- Methyltransferases - antagonists & inhibitors
- Neoplasms - genetics
- Neoplasms - therapy
- Subjects (LCSH)
- Cancer - Treatment
- Cancer - Genetic aspects
- Neoplasms - therapy
- Neoplasms - genetics
- Abstract
- The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders such as myeloid leukemias and preleukemias (myelodysplasias) is now being translated into treatment approaches that target the epigenetic defects pharmacologically. Such approaches include reactivation of tumor suppressor genes and other antiproliferative genes by reversal of DNA hypermethylation through azanucleosides, and use of HDAC inhibitors to reverse gene silencing mediated by chimeric, leukemia-specific transcription factors. This book first presents the latest evidence derived from preclinical models regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epigenetic disturbances in lung cancer and other solid tumors is then discussed. A major part of the book, however, relates specifically to the translation of basic research and drug development to clinical applications, and in this context both present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.
- Contents
- The fundamental role of epigenetic regulation for normal and disturbed all growth and differentiation -- Mouse models to study DNA methylation in cancer research -- Epigenetic regulation of normal hematopoietic development -- Epigenetic regulation of globin genes and disturbances in hemoglobinopathies -- DNA methylation abnormalities in hematopoietic disorders: biological significance and methodological approaches -- Epigenetic modifications mediated by the AML1/ETO and MLL leukemia fusion proteins -- Epigenetic abnormalities in lung cancer -- Pharmacodynamic responses to DNA methyltransferase inhibition -- Histone methyltransferases: opportunities in cancer drug discovery -- Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy -- Clinical implications of epigenetic alterations in lung cancer -- Epigenetic disturbances in colorectal cancer -- Epigenetic therapies in solid tumours: from preclinical models to clinical trial results.
- Format
- e-Book
- Location
- Online
Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care
https://libcat.nshealth.ca/en/permalink/provcat38923
Alan David Kaye, Adam M. Kaye, Richard D. Urman, editors.
--New York, NY:
Springer
, c2015.
- Available Online
- View e-Book
- Location
- Online
In anesthesiology, pain medicine, and critical care, practitioners at all levels need help to stay current with the continually evolving drug knowledge-base, and trainees need tools to prepare for in-training and board exams that increasingly test their knowledge of pharmacology. This practical book is aimed at both readerships. It features a unique and practical chapter on the United States Food and Drug Administration (FDA) "black box" warnings that describe what safety precautions should be …
- Available Online
- View e-Book
- Other Authors
- Kaye, Alan David
- Kaye, Adam M
- Urman, Richard D
- Responsibility
- Alan David Kaye, Adam M. Kaye, Richard D. Urman, editors
- Place of Publication
- New York, NY
- Publisher
- Springer
- Date of Publication
- c2015
- Physical Description
- 1 online resource (xxii, 904 p. : 221 illus., 36 illus. in color)
- ISBN
- 9781461489481
- 9781461489474 (print ed.)
- Subjects (MeSH)
- Analgesics - pharmacology
- Anesthetics - pharmacology
- Critical Care
- Pain - drug therapy
- Pharmacology
- Abstract
- In anesthesiology, pain medicine, and critical care, practitioners at all levels need help to stay current with the continually evolving drug knowledge-base, and trainees need tools to prepare for in-training and board exams that increasingly test their knowledge of pharmacology. This practical book is aimed at both readerships. It features a unique and practical chapter on the United States Food and Drug Administration (FDA) "black box" warnings that describe what safety precautions should be taken with commonly used drugs. The editors and contributors are pharmacology experts representing a cross-section of clinical specialties and institutions in the United States and include pharmacologists, pharmacists, as well as physicians.
- Contents
- Part I. Basic Pharmacologic Principles -- 1. Pharmacokinetics and Pharmacodynamics of Anesthetics -- 2. A Review of Mechanisms of Inhalational Anesthetic Agents -- 3. Pharmacokinetics, pharmacodynamics and physical properties of Inhalational agents -- 4. Principles of Total Intravenous Anesthesia -- 5. Perioperative Considerations in Pharmacology -- Part II. Drug Classes -- 6. Anesthetic Induction Agents -- 7. Analgesics: Opiate agonists, mixed agonist/antagonists and antagonists for acute pain management -- 8. Analgesics: Opioids for chronic pain management and surgical considerations -- 9. Nonopioid Analgesic and Adjunct Drugs -- 10. Benzodiazepines and muscle relaxants -- 11. Pharmacology of Local Anesthetics -- 12. Neuromuscular Blockers -- 13. Reversal agents -- 14. Drugs acting on the autonomic nervous system -- 15. Antihypertensives, diuretics and antidysrhythmics -- 16. Peripheral vasodilators -- 17. Nitric oxide and Pulmonary Vasodilators -- 18. Asthma and COPD agents -- 19. Hormones, Part 1: Thyroid and Corticosteroid Hormones -- 20. Hormones, Part 2: Insulin and Other glucose controlling Medications -- 21. Antacids, Gastrointestinal Prokinetics, And Proton Pump Inhibitors -- 22. Histamine modulators -- 23. Central Nervous System Stimulants -- 24. Anticoagulant drugs -- 25. Hemostatic Agents -- 26. Blood, Blood Products, and Substitutes -- 27. Antipyretics: Acetaminophen, Arachidonic Acid Agents, Cox1 And Cox2 Inhibitors -- 28. Antiemetic Agents -- 29. Antiepileptics agents -- 30. Neuropharmacologic agents for neurologic conditions -- 31. Chemotherapeutic Agents -- 32. Antimicrobial Agents -- 33. Herbals medications and vitamin supplements -- 34. Minerals and electrolytes -- 35. Disinfection agents and antiseptics -- 36. Psychopharmacologic agents and psychiatric drug considerations -- 37. Cocaine, Methamphetamine, MDMA and Heroin -- Part III. Clinical Subspecialties -- 38. Cardiac surgery -- 39. The Intensive Care Unit -- 40. Enteral and parenteral nutrition -- 41. Obstetrics -- 42. Pediatrics -- 43. Neurologic Surgery -- 44. Liver disease and liver transplantation -- Part IV. Special Topics -- 45. Black Box FDA warnings and legal implications -- 46. Drug-Induced QT Prolongation -- 47. Drugs and Cancer Propagation -- 48. Lipid Lowering Agents -- 49. Serotonin Syndrome -- Part V. New Vistas in Pharmacology -- 50. Novel Psychoactive Substances: synthetic cathinones and cannabinoid receptor agonists -- 51. New Vistas in Anesthetics, IV Induction Agents -- 52. New Vistas In Neuromuscular Blockers -- 53. Patient-Controlled Analgesia: The Importance of Effector Site Pharmacokinetics -- 54. Understanding anesthesia-induced memory loss -- 55. Novel Targets of Current Analgesic Drug Development.
- Format
- e-Book
- Location
- Online
Essentials of SGLT2 Inhibitors in Diabetes
https://libcat.nshealth.ca/en/permalink/provcat41469
Miles Fisher, Gerard McKay.
--Cham:
Adis
, 2017.
- Available Online
- View e-Book
- Location
- Online
Written by experts in the field, this clinical handbook explores the novel SGLT2 drug class for the treatment of diabetes. This book includes evidence-based guidelines, major clinical trials, and a discussion of treatment options currently available, as well as those currently in development. Essentials of SGLT2 Inhibitors is an ideal educational resource for busy medical professionals who need to stay up-to-date with diabetes treatment advances in order to provide the best possible clinical ca…
- Available Online
- View e-Book
- Author
- Fisher, Miles
- Other Authors
- McKay, Gerard
- Responsibility
- Miles Fisher, Gerard McKay
- Place of Publication
- Cham
- Publisher
- Adis
- Date of Publication
- 2017
- Physical Description
- 1 online resource (xi, 68 pages) : 13 illus. in color
- ISBN
- 9783319432960
- 9783319432946 (print ed.)
- Subjects (MeSH)
- Diabetes Mellitus, Type 2 - drug therapy
- Drug Design
- Sodium-Glucose Transporter 2 - antagonists & inhibitors
- Abstract
- Written by experts in the field, this clinical handbook explores the novel SGLT2 drug class for the treatment of diabetes. This book includes evidence-based guidelines, major clinical trials, and a discussion of treatment options currently available, as well as those currently in development. Essentials of SGLT2 Inhibitors is an ideal educational resource for busy medical professionals who need to stay up-to-date with diabetes treatment advances in order to provide the best possible clinical care for their patients.
- Contents
- Overview of Type 2 Diabetes -- SGLT2 Inhibitors for Treating Diabetes -- Guidelines for the Treatment of Type 2 Diabetes Mellitus -- Using SGLT2 Inhibitors in Special Populations.
- Format
- e-Book
- Publication Type
- Handbook
- Location
- Online
Handbook of oral anticoagulation
https://libcat.nshealth.ca/en/permalink/provcat33540
editors, Gregory YH Lip, Eduard Shantsila ; contributors, Deirdre A. Lane, Chee W. Khoo, Kok Hoon Tay, Suresh Krishnamoorthy, Stavros Apostolakis.
(Second edition)
--London:
Springer Healthcare
, c2013.
- Available Online
- View e-Book
- Location
- Online
This book covers a wide range of disorders such as atrial fibrillation, artificial heart valves, deep vein thrombosis, pulmonary embolism and stroke. Handbook of Oral Anticoagulation aims to provide an accessible overview of the exciting new developments in this field. Incorporating numerous quick-reference tables and figures and fully referenced throughout to key papers and the latest reviews, it will be a useful resource for all healthcare professionals involved in thromboprophylaxis.
- Available Online
- View e-Book
- Other Authors
- Lip, Gregory Y. H
- Shantsila, Eduard
- Responsibility
- editors, Gregory YH Lip, Eduard Shantsila ; contributors, Deirdre A. Lane, Chee W. Khoo, Kok Hoon Tay, Suresh Krishnamoorthy, Stavros Apostolakis
- Edition
- Second edition
- Place of Publication
- London
- Publisher
- Springer Healthcare
- Date of Publication
- c2013
- Physical Description
- 1 online resource (ix, 88 pages)
- ISBN
- 9781908517968 (electronic bk.)
- 9781908517586
- Subjects (MeSH)
- Anticoagulants - administration & dosage
- Anticoagulants - adverse effects
- Anticoagulants - therapeutic use
- Subjects (LCSH)
- Anticoagulants - Handbooks
- Anticoagulants (Medicine)
- Cardiology
- Hematology
- General Practice / Family Medicine
- Primary Care Medicine
- Pharmacotherapy
- Abstract
- This book covers a wide range of disorders such as atrial fibrillation, artificial heart valves, deep vein thrombosis, pulmonary embolism and stroke. Handbook of Oral Anticoagulation aims to provide an accessible overview of the exciting new developments in this field. Incorporating numerous quick-reference tables and figures and fully referenced throughout to key papers and the latest reviews, it will be a useful resource for all healthcare professionals involved in thromboprophylaxis.
- Contents
- The Coagulation Pathway and Approaches to Anticoagulation -- Common Clinical Indications for Anticoagulation -- Vitamin K Antagonists and Their Limitations -- Hemorrhage Risks, Patient Perspectives, and Quality-of-Life Issues -- New Oral Anticoagulants -- Future Directions.
- Format
- e-Book
- Location
- Online
